NEW YORK (360Dx) – BioMérieux this week released consolidated financial statements for the year ended Dec. 31, 2017, confirming the earnings it reported in January. For the full-year 2017, the firm reported that total revenues rose 9 percent to €2.29 billion ($2.82 billion) from €2.10 billion in 2016. The company also reported that the net income of its consolidated companies rose to €238 million, or €2.02 per share, in 2017, from €179 million, or €1.52 per share, in 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.